chlormadinone acetate has been researched along with uracil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ezaki, K; Hayahara, N; Iritani, M; Kashihara, N; Maekawa, T; Morikawa, Y; Nishijima, T; Senju, M; Tsujita, M; Yamaguchi, M | 1 |
| Fujimoto, N; Harada, S; Hida, T; Matsumoto, T | 1 |
1 trial(s) available for chlormadinone acetate and uracil
| Article | Year |
|---|---|
[Endocrine chemotherapy for prostatic cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlormadinone Acetate; Follow-Up Studies; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate; Tegafur; Uracil | 1994 |
2 other study(ies) available for chlormadinone acetate and uracil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[Long-term survival of hormone-refractory prostate cancer: a case report].
Topics: Adenocarcinoma; Administration, Oral; Aged; Androgen Antagonists; Chlormadinone Acetate; Combined Modality Therapy; Enzyme Inhibitors; Humans; Male; Orchiectomy; Prostatic Neoplasms; Survivors; Tegafur; Uracil | 2001 |